Tyrosine Kinase

Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-   B1301 A 419259 trihydrochlorideSummary: LCK inhibitor, orally available B1301 A 419259 trihydrochlorideSummary: LCK inhibitor, orally available
-   B1543 Mubritinib (TAK 165)Target: ErbBSummary: Potent inhibitor of HER2/ErbB2 B1543 Mubritinib (TAK 165)Target: ErbBSummary: Potent inhibitor of HER2/ErbB2
-   A3320 CO-1686 (AVL-301)1 CitationTarget: EGFRSummary: EGFR inhibitor A3320 CO-1686 (AVL-301)1 CitationTarget: EGFRSummary: EGFR inhibitor
-   A3751 Regorafenib monohydrateSummary: Tyrosine kinase inhibitor A3751 Regorafenib monohydrateSummary: Tyrosine kinase inhibitor
-   A5096 PF-04217903Target: c-METSummary: C-Met inhibitor,selective and ATP-competitive A5096 PF-04217903Target: c-METSummary: C-Met inhibitor,selective and ATP-competitive
-   A8350 AZD4547Target: FGFRSummary: FGFR inhibitor A8350 AZD4547Target: FGFRSummary: FGFR inhibitor
-   A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: IGF-IR/IR/ALK inhibitor, ATP-competitive A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: IGF-IR/IR/ALK inhibitor, ATP-competitive
-   A8528 TAK-285Target: EGFR|HER2Summary: HER2/EGFR(HER1) inhibitor A8528 TAK-285Target: EGFR|HER2Summary: HER2/EGFR(HER1) inhibitor
-   A8607 PPY ATarget: Abl kinasesSummary: Abl kinases inhibitor A8607 PPY ATarget: Abl kinasesSummary: Abl kinases inhibitor
-   B1299 1-NM-PP1Target: Cyclin-Dependent Kinases|Bcr-Abl|Src|Ca2 /calmodulin-dependent protein kinases (CaMKs)|c-FynSummary: Pp60c-src inhibitor B1299 1-NM-PP1Target: Cyclin-Dependent Kinases|Bcr-Abl|Src|Ca2 /calmodulin-dependent protein kinases (CaMKs)|c-FynSummary: Pp60c-src inhibitor
